Quanterix Corporation (QTRX)
NASDAQ: QTRX · Real-Time Price · USD
2.870
-0.200 (-6.51%)
At close: Oct 16, 2026, 4:00 PM EDT
2.910
+0.040 (1.39%)
Pre-market: Oct 19, 2026, 8:17 AM EDT
Quanterix Employees
Quanterix had 450 employees as of December 31, 2025. The number of employees decreased by 21 or -4.46% compared to the previous year. That makes Quanterix the 20,883rd largest employer in the world and 2,769th in the United States.
Employees
450
Change (1Y)
-21
Growth (1Y)
-4.46%
Revenue / Employee
$340,909
Profits / Employee
-$273,573
Market Cap
135.73M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 450 | -21 | -4.46% |
| Dec 31, 2024 | 471 | 30 | 6.80% |
| Dec 31, 2023 | 441 | 71 | 19.19% |
| Dec 31, 2022 | 370 | -90 | -19.57% |
| Dec 31, 2021 | 460 | 146 | 46.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Inogen | 753 |
| Neuronetics | 658 |
| RxSight | 461 |
| Apyx Medical | 205 |
| Profound Medical | 162 |
| Nyxoah | 154 |
| Owlet | 114 |
| TriSalus Life Sciences | 102 |
QTRX News
- 6 days ago - Quanterix price target raised to $3.50 from $3 at TD Cowen - TheFly
- 12 days ago - Quanterix, Innovita announce NMPA approvals for SIMOA tech, testing - TheFly
- 12 days ago - Quanterix and Innovita Expand IVD Access in China with National Medical Products Administration Approvals - Business Wire
- 24 days ago - Quanterix reports progress on Content Innovation Engine - TheFly
- 24 days ago - Quanterix Delivers on Spatial Biology Content Innovation Commitments at ESSB 2026 - Business Wire
- 4 weeks ago - Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 5 weeks ago - Quanterix appoints Yuri Fesko as CMO - TheFly
- 5 weeks ago - Quanterix Names Dr. Yuri Fesko Chief Medical Officer - Business Wire